This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Heather Jane McNaughton: Innovator in Clavam Derivatives
Introduction: Heather Jane McNaughton is a distinguished inventor located in Oxford, Great Britain. With an innovative spirit, she has contributed to the field of biochemistry through her unique patent. McNaughton's work primarily focuses on the synthesis of clavam compounds, which has significant implications in the medical and pharmaceutical industries.
Latest Patents: Heather Jane McNaughton holds a patent titled "Process for preparing clavam derivatives by using polypeptides having β-lactam synthetase activity." This invention outlines a novel method for synthesizing clavam compounds, especially clavulanic acid. The patent details the use of β-lactam synthetase polypeptides and polynucleotides, along with recombinant materials and production methods. Such advancements are crucial for developing new therapeutic agents.
Career Highlights: McNaughton’s career has been marked by her impactful contributions to biochemistry. Her role at SmithKline Beecham Corporation has enabled her to further her research and innovations in the synthesis of essential compounds. With a robust educational background and professional experience, she has established herself as a key player in her field.
Collaborations: Throughout her career, Heather has collaborated with notable colleagues, including Barry Barton and Christopher Joseph Schofield. These collaborations have fostered a productive environment for research and development, leading to significant innovations in their respective areas of expertise.
Conclusion: Heather Jane McNaughton is a prominent figure in the realm of innovations within the biochemistry sector. Her patent related to clavam derivatives demonstrates her commitment to advancing scientific knowledge and practices. With continued research and collaboration, McNaughton is poised to make even greater contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile